Clinical characteristics and risk factors for a distinct pustular psoriasis flare after withdrawal of biologics in plaque psoriasis
Journal of the American Academy of Dermatology · 2026-09
DOI: 10.1016/j.jaad.2026.09.082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-09. Verfasst von Hsien-Yi Chiu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan; Department of Dermatology, College of Medicine, National Taiwan Unive…. Die Arbeit nennt 22 Literaturangaben. Gefördert von: National Taiwan University Hospital Hsin-Chu Branch, Taiwan Ministry of Science and Technology, Chang Gung Memorial Hospital.
Abstract (Originalsprache)
BACKGROUND: Although biologics are effective in treating psoriasis, a subset of patients experience severe relapse after treatment discontinuation. OBJECTIVE: To delineate the features and risk factors for a distinct pustular psoriasis flare following biologic withdrawal. METHODS: This multicenter study included treatment episodes from patients with psoriasis who responded to and subsequently discontinued biologic therapy between 2011 and 2025. Clinical features of this distinct pustular psoriasis flare were characterized, and associated factors were assessed using a generalized estimating equation model. RESULTS: These pustular psoriasis flares occurred in 86 of 1198 treatment episodes (7.2%) and were characterized by painful, diffuse, intense erythema with pustules and swelling, predominantly involving the lower limbs. The occurrence of these flares increased with a higher number of cycles of biologic withdrawal-relapse episodes. A family history of psoriasis, concomitant psoriatic arthritis, a prior episode of this flare phenotype, a higher number of previous biologic withdrawal-relapse episodes, and longer time to achieve Psoriasis Area and Severity Index 50 during biologic therapy were independently associated with this distinct pustular psoriasis flare. LIMITATIONS: Nonrandomized allocation of treatment and lack of histologic and molecular data. CONCLUSIONS: Vigilant monitoring and early treatment resumption are recommended for patients with risk factors for pustular psoriasis flares after biologic withdrawal.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan; Department of Dermatology, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Dermatology, National Taiwan Univ…
- Department of Dermatology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan; Department of Dermatology, School of Medicine, Tzu-Chi University, Hualien, Taiwan.
- Department of Dermatology, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan, Taiwan; School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Dermatology, Drug Hypersensitivity…
Förderung
- National Taiwan University Hospital Hsin-Chu Branch
- Taiwan Ministry of Science and Technology
- Chang Gung Memorial Hospital
Zitieren
APA
Chiu, H. Y., Hung, S. J., & Huang, Y. H. (2026). Clinical characteristics and risk factors for a distinct pustular psoriasis flare after withdrawal of biologics in plaque psoriasis. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.09.082
Vancouver
Chiu HY, Hung SJ, Huang YH. Clinical characteristics and risk factors for a distinct pustular psoriasis flare after withdrawal of biologics in plaque psoriasis. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2026.09.082
BibTeX
@article{Chiu2026,
author = {Chiu, Hsien-Yi and Hung, Sung Jen and Huang, Yu-Huei},
title = {Clinical characteristics and risk factors for a distinct pustular psoriasis flare after withdrawal of biologics in plaque psoriasis},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
doi = {10.1016/j.jaad.2026.09.082}
}
EUVIMED